1. Home
  2. |Insights
  3. |SBA Proposes Set-Aside Rules For Women-Owned Small Businesses

SBA Proposes Set-Aside Rules For Women-Owned Small Businesses

Client Alert | less than 1 min read | 01.02.08

After years of delay, the Small Business Administration proposed new regulations allowing set-asides for women-owned small businesses (WOSB) and economically disadvantaged WOSB's. Agencies may restrict competition to these businesses, but only in certain procurements valued at $3 million ($5 million for manufacturing) or less, only in industries where SBA finds WOSB are “underrepresented,” and only where the agency determines that the restriction would not violate the Equal Protection Clause of the Constitution.

Contacts

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights